Pill imprint N S1 has been identified as Sucralfate 1 g.
Sucralfate is used in the treatment of stomach ulcer; gerd; stomatitis; duodenal ulcer; hyperphosphatemia of renal failure (and more), and belongs to the drug class miscellaneous GI agents. There is no proven risk in humans during pregnancy.
Sucralfate 1 g is not subject to the Controlled Substances Act.
- Lortab Information for Consumers
- Lortab Information for Healthcare Professionals (includes dosage details)
- Side Effects of Lortab (detailed)
Search for questions
Still looking for answers? Try searching for what you seek or ask your own question.
Posted 20 Dec 2009 • 1 answer
Posted 13 May 2010 • 2 answers
Posted 24 Mar 2011 • 1 answer
Posted 7 Jun 2011 • 1 answer
Posted 13 Jun 2016 • 1 answer